In-depth Analysis Report
Representative Director Jung Yoo-suk
The Line Plastic Surgery, established in 2007, is a mid-sized clinic on Garosu-gil, specializing in body contouring and anti-aging with Stem Cell technology.
A plastic surgery specialist with ~30 years of clinical experience, renowned for 'Sato-style double eyelid', facelifts, and breast surgery expertise.
Achieved JCI accreditation (2015-2018) and operates an in-house stem cell lab (Cell Matrix Lab) to enhance fat grafting outcomes.
Promotes a '3-No System' and maintains high ratings on cosmetic medical apps, alongside transparently addressing industry-common concerns.
"Plastic surgery is a process of self-creation where one's own judgment and decision are important."
Director Jung Yoo-suk values highlighting the individuality of each patient rather than adhering to standardized beauty. He focuses on understanding what patients truly want and suggesting suitable, not unreasonable, surgical directions.
Co-representative director of The Line Plastic Surgery and a plastic surgery specialist. Graduated from Kyung Hee University College of Medicine and completed his plastic surgery residency there. Possesses approximately 30 years of abundant clinical experience.
The Line Plastic Surgery opened in 2007 and relocated to its current location in Garosu-gil (Dongnam Building), Sinsa-dong, Gangnam-gu, Seoul, in September 2017. Beyond simple cosmetic surgery, the hospital advocates 'Stem Cell Body Contouring Focused Treatment' and operates an integrated system comprising a Plastic Surgery Center, Dermatology Center, and Stem Cell Research Institute.
A representative procedure of Director Jung Yoo-suk, directly passed down from Dr. Sato, a renowned Japanese plastic surgeon.
The Line Plastic Surgery actively integrates stem cell (SVF) technology into liposuction and grafting surgeries.
Director Jung Yoo-suk also possesses significant expertise in facelift procedures.
The Line Plastic Surgery is a hospital providing advanced medical services, combining Representative Director Jung Yoo-suk's long clinical experience with the technical infrastructure of a Stem Cell Research Institute. It occupies a differentiated market position through specialized procedure branding such as Sato-style Double Eyelid and Heo-Gol-Seung. The history of JCI accreditation and the university hospital cooperation system are indicators showing the hospital's commitment to patient safety, and high ratings from actual patients suggest these systems operate positively in the clinical field.
When deciding on surgery, it is important to verify the safety devices provided by the hospital (CCTV, real-name specialist system, etc.) and select a procedure suitable for the individual through sufficient consultation with medical staff.